Viewing Study NCT05262959


Ignite Creation Date: 2025-12-24 @ 2:56 PM
Ignite Modification Date: 2026-01-18 @ 6:11 PM
Study NCT ID: NCT05262959
Status: COMPLETED
Last Update Posted: 2024-08-13
First Post: 2022-02-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC
Sponsor: Shanghai Zhongshan Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Donafenib View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Donafenib View
None Hepatocellular Carcinoma View